Financhill
Back

Immutep Quote, Financials, Valuation and Earnings

Immutep Price Quote

$2.10
+0.02 (+-0.94%)
(Updated: December 21, 2024 at 5:31 AM ET)

Immutep Key Stats

Buy
65
Immutep (IMMP) is a Buy

Day range:
$2.04 - $2.17
52-week range:
$1.66 - $3.34
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
2.38%

Volume:
120.7K
Avg. volume:
156.4K
1-year change:
-11.32%
Market cap:
$301.8M
Revenue:
$0
EPS:
$0

How Much Does Immutep Make?

Data Unavailable

Is Immutep Growing As A Company?

Data Unavailable

Immutep Stock Price Performance

  • Did Immutep Stock Go Up Last Month?
    Immutep share price went up by 5.87% last month
  • Did IMMP's Share Price Rise Over The Last Year?
    IMMP share price fell by -11.32% over the past 1 year

What Is Immutep 52-Week High & Low?

  • What Is Immutep’s 52-Week High Share Price?
    Immutep has traded as high as $3.34 over the past 52 weeks
  • What Is Immutep’s 52-Week Low Share Price?
    Immutep has traded as low as $1.66 over the past 52 weeks

Immutep Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Immutep?

Data Unavailable

Is Immutep Cash Flow Positive?

Data Unavailable

Immutep Return On Invested Capital

Data Unavailable

Immutep Earnings Date & Stock Price

  • What Is Immutep's Stock Price Today?
    A single share of IMMP can be purchased today for 2.08
  • What Is Immutep’s Stock Symbol?
    Immutep trades on the nasdaq under the ticker symbol: IMMP
  • When Is Immutep’s Next Earnings Date?
    The next quarterly earnings date for Immutep is scheduled on February 27, 2025
  • When Is IMMP's next ex-dividend date?
    Immutep's next ex-dividend date is May 20, 2020
  • How To Buy Immutep Stock?
    You can buy Immutep shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

Immutep Competitors

  • Who Are Immutep's Competitors?
    Below is a list of companies who compete with Immutep or are related in some way:
    • Alterity Therapeutics Ltd (ATHE)
    • Immuron Ltd (IMRN)
    • Kazia Therapeutics Ltd (KZIA)
    • Mesoblast Ltd (MESO)
    • Opthea Ltd (OPT)

Immutep Dividend Yield

Data Unavailable

Immutep Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 0%
Revenue: 0% 0%

Analyst Recommendations

Buy Recommendations: 2
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 8.43
Upside from Last Price: 306.43%

Major Shareholders

Data Unavailable